Cargando…

Treatment of adult brainstem glioma with combined antiangiogenic therapy: a case report and literature review

Adult brainstem gliomas belong to a rare and heterogeneous group of brain tumors. The overall prognosis is poor; therapeutic options are limited, given the resistance to radiotherapy and the unclear role of chemotherapy/antiangiogenic therapy. Apatinib, a tyrosine kinase inhibitor that selectively i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Dongdong, Han, Guang, Liu, Huali, Gao, Likun, Verma, Vivek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388961/ https://www.ncbi.nlm.nih.gov/pubmed/30863099 http://dx.doi.org/10.2147/OTT.S195783

Ejemplares similares

Antiangiogenic Therapy for Glioma
por: Cea, Valentina, et al.
Publicado: (2012)

Brainstem Glioma in Adults
por: Hu, Jethro, et al.
Publicado: (2016)

Progress on Antiangiogenic Therapy for Patients with Malignant Glioma
por: Ahluwalia, Manmeet S., et al.
Publicado: (2010)

Antiangiogenic Therapy in the Treatment of Recurrent Medulloblastoma in the Adult: Case Report and Review of the Literature
por: Privitera, Giuseppe, et al.
Publicado: (2009)

Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma
por: Rahman, Ruman, et al.
Publicado: (2010)

Combined Treatment With Radiotherapy and Immunotherapy for Isocitrate Dehydrogenase Mutant Brainstem Glioma in Adult: A Case Report
por: Morimoto, Takayuki, et al.
Publicado: (2022)

Antiangiogenic Therapy for Patients with Recurrent and Newly Diagnosed Malignant Gliomas
por: Shirai, Katsuyuki, et al.
Publicado: (2012)

IDH‐mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature
por: Chang, Ellen K., et al.
Publicado: (2021)

Angiocentric glioma of brainstem
por: Almubarak, Abdulaziz O., et al.
Publicado: (2020)

Adult isocitrate dehydrogenase–mutant brainstem glioma: illustrative case
por: Ye, Vincent C., et al.
Publicado: (2021)

EphB4 mediates resistance to antiangiogenic therapy in experimental glioma
por: Uhl, Christian, et al.
Publicado: (2018)

Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma
por: Chen, Zhuo, et al.
Publicado: (2015)

Differences between brainstem gliomas in juvenile and adult rats
por: WANG, YU, et al.
Publicado: (2013)

Malignant Progression of an IDH Mutant Brainstem Glioma in Adult
por: SANO, Kenshi, et al.
Publicado: (2021)

Antiangiogenic therapy
por: Avitabile, T
Publicado: (2010)

Medullary brainstem gliomas in an adult: A rare case report and challenging tumor
por: Aleid, Abdulsalam Mohammed, et al.
Publicado: (2023)

Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature
por: Leibetseder, Annette, et al.
Publicado: (2021)

Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma
por: Hou, Liubing, et al.
Publicado: (2022)

Radiotherapy combined or not with chemotherapy in adult or pediatric patients with brainstem glioma: a population-based study
por: Moraes, Fabio Y., et al.
Publicado: (2023)

Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature
por: Khattab, Mohamed H., et al.
Publicado: (2015)

An affinity for brainstem microglia in pediatric high-grade gliomas of brainstem origin
por: Zats, Liat Peretz, et al.
Publicado: (2022)

The inefficacy of antiangiogenic therapies
por: Ribatti, Domenico
Publicado: (2010)

Antiangiogenic Cancer Therapy
por: Maxwell, P H, et al.
Publicado: (2009)

Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment
por: Yuan, Meng, et al.
Publicado: (2022)

Pediatric Brainstem Gliomas: An Institutional Experience
por: Laghari, Altaf Ali, et al.
Publicado: (2019)

Antiangiogenic therapy for primitive neuroectodermal tumor with thalidomide: A case report and review of literature
por: Li, Qing, et al.
Publicado: (2017)

Pro- and Antiangiogenic Factors in Gliomas: Implications for Novel Therapeutic Possibilities
por: Groblewska, Magdalena, et al.
Publicado: (2021)

Case Report: Clinicopathological and Genetic Features of IDH-Mutant Brainstem Glioma in Adults: Report of Five Cases
por: Zhou, Jiangfen, et al.
Publicado: (2022)

Lack of Efficacy of Combined Antiangiogenic Therapies in Xenografted Human Melanoma
por: Adamcic, Una, et al.
Publicado: (2012)

Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
por: Hashizume, Rintaro, et al.
Publicado: (2014)

The Survival Benefits of Surgical Resection and Adjuvant Therapy for Patients With Brainstem Glioma
por: Liu, Zhuoyi, et al.
Publicado: (2021)

Intraparenchymal papillary meningioma of brainstem: case report and literature review
por: Jiang, Xiao-Bing, et al.
Publicado: (2012)

Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy
por: Xu, Hui, et al.
Publicado: (2015)

Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma
por: Acker, Güliz, et al.
Publicado: (2018)

Antiangiogenic therapy for breast cancer
por: Nielsen, Dorte Lisbet, et al.
Publicado: (2010)

Antiangiogenic therapies in ovarian cancer
por: Reinthaller, Alexander
Publicado: (2016)

Antiangiogenic therapy in breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2017)

Antiangiogenic Therapy for Diabetic Nephropathy
por: Tanabe, Katsuyuki, et al.
Publicado: (2017)

The integrated genomic and epigenomic landscape of brainstem glioma
por: Chen, Lee H., et al.
Publicado: (2020)

Role of neuronavigation in the surgical management of brainstem gliomas
por: Zhang, Mingxin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mnrr3c19qavv4csc7llff8ojhi